Targeting the Cell Cycle to Kill Cancer Cells

Pharmacology

Volumn , Issue , 2009, Pages 429-453

  Taylor, William R ^a   Grabovich, Aaron ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882514921     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-369521-5.00017-8     Document Type: Chapter

References (209)

1. Agarwal M.K., Hastak K., Jackson M.W., Breit S.N., Stark G.R., Agarwal M.L. Macrophage inhibitory cytokine 1 mediates a p53-dependent protective arrest in S phase in response to starvation for DNA precursors. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:16278-16283.
2. Agarwal M.L., Agarwal A., Taylor W.R., Chernova O., Sharma Y., Stark G.R. A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:14775-14780.
3. Ainsztein A.M., Kandels-Lewis S.E., Mackay A.M., Earnshaw W.C. INCENP centromere and spindle targeting: Identification of essential conserved motifs and involvement of heterochromatin protein HP1. The Journal of Cell Biology 1998, 143:1763-1774.
4. Aklilu M., Kindler H.L., Donehower R.C., Mani S., Vokes E.E. Phase II study of flavopiridol in patients with advanced colorectal cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology / ESMO 2003, 14:1270-1273.
5. Andreassen P.R., Lohez O.D., Lacroix F.B., Margolis R.L. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Molecular Biology of the Cell 2001, 12:1315-1328.
6. Bakkenist C., Kastan M. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation [In Process Citation]. Nature 2003, 421:499-506.
7. Banin S., Moyal L., Shieh S., Taya Y., Anderson C.W., Chessa L., et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998, 281:1674-1677.
8. Bekker-Jensen S., Lukas C., Kitagawa R., Melander F., Kastan M.B., Bartek J., et al. Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. The Journal of Cell Biology 2006, 173:195-206.
9. Bischoff J.R., Anderson L., Zhu Y., Mossie K., Ng L., Souza B., et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. The EMBO Journal 1998, 17:3052-3065.
10. Booher R.N., Holman P.S., Fattaey A. Human Myt1 is a cell cycle-regulated kinase that inhibits CDC2 but not CDK2 activity. The Journal of Biological Chemistry 1997, 272:22300-22306.
11. Borel F., Lohez O.D., Lacroix F.B., Margolis R.L. Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket protein-compromised cells. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:9819-9824.
12. Borgne A., Ostvold A.C., Flament S., Meijer L. Intra-M phase-promoting factor phosphorylation of cyclin B at the prophase/metaphase transition. The Journal of Biological Chemistry 1999, 274:11977-11986.
13. Bressan D., Baxter B., Petrini J. The Mre11-Rad50-Xrs2 protein complex facilitates homologous recombination-based double-strand break repair in Saccharomyces cerevisiae. Molecular and Cellular Biology 1999, 19:7681-7687.
14. Buffin E., Lefebvre C., Huang J., Gagou M.E., Karess R.E. Recruitment of Mad2 to the kinetochore requires the Rod/Zw10 complex. Current Biology: CB 2005, 15:856-861.
15. Bulavin D.V., Higashimoto Y., Popoff I.J., Gaarde W.A., Basrur V., Potapova O., et al. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 2001, 411:102-107.
16. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998, 282:1497-1501.
17. Byun T.S., Pacek M., Yee M.C., Walter J.C., Cimprich K.A. Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint. Genes & Development 2005, 19:1040-1052.
18. Canman C.E., Lim D.S., Cimprich K.A., Taya Y., Tamai K., Sakaguchi K., et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998, 281:1677-1679.
19. Cao L.G., Wang Y.L. Signals from the spindle midzone are required for the stimulation of cytokinesis in cultured epithelial cells. Molecular Biology of the Cell 1996, 7:225-232.
20. Carter T.A., Wodicka L.M., Shah N.P., Velasco A.M., Fabian M.A., Treiber D.K., et al. Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:11011-11016.
21. Castedo M., Coquelle A., Vivet S., Vitale I., Kauffmann A., Dessen P., et al. Apoptosis regulation in tetraploid cancer cells. The EMBO Journal 2006, 25:2584-2595.
22. Cazales M., Schmitt E., Montembault E., Dozier C., Prigent C., Ducommun B. CDC25B phosphorylation by Aurora-A occurs at the G2/M transition and is inhibited by DNA damage. Cell Cycle (Georgetown, Tex.) 2005, 4:1233-1238.
23. Chang B.D., Broude E.V., Fang J.V.K.T., Abdryashitov R., Poole J.C., Roninson I.B. p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene 2000, 19:2165-2170.
24. Chang J.L., Chen T.H., Wang C.F., Chiang Y.H., Huang Y.L., Wong F.H., et al. Borealin/Dasra B is a cell cycle-regulated chromosomal passenger protein and its nuclear accumulation is linked to poor prognosis for human gastric cancer. Experimental Cell Research 2006, 312:962-973.
25. Chaturvedi P., Eng W.K., Zhu Y., Mattern M.R., Mishra R., Hurle M.R., et al. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 1999, 18:4047-4054.
26. Chieffi P., Cozzolino L., Kisslinger A., Libertini S., Staibano S., Mansueto G., et al. Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. The Prostate 2006, 66:326-333.
27. Cimini D., Howell B., Maddox P., Khodjakov A., Degrassi F., Salmon E.D. Merotelic kinetochore orientation is a major mechanism of aneuploidy in mitotic mammalian tissue cells. The Journal of Cell Biology 2001, 153:517-527.
28. Cliby W.A., Roberts C.J., Cimprich K.A., Stringer C.M., Lamb J.R., Schreiber S.L., et al. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. The EMBO Journal 1998, 17:159-169.
29. Clifford B., Beljin M., Stark G.R., Taylor W.R. G2 arrest in response to topoisomerase II inhibitors: The role of p53. Cancer Research 2003, 63:4074-4081.
30. Coulonval K., Bockstaele L., Paternot S., Roger P.P. Phosphorylations of cyclin-dependent kinase 2 revisited using two-dimensional gel electrophoresis. The Journal of Biological Chemistry 2003, 278:52052-52060.
31. De Souza C.P., Ellem K.A., Gabrielli B.G. Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events. Experimental Cell Research 2000, 257:11-21.
32. Deming P.B., Cistulli C.A., Zhao H., Graves P.R., Piwnica-Worms H., Paules R.S., et al. The human decatenation checkpoint. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:12044-12049.
33. Deming P.B., Flores K.G., Downes C.S., Paules R.S., Kaufmann W.K. ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase. The Journal of Biological Chemistry 2002, 277:36832-36838.
34. Ditchfield C., Johnson V.L., Tighe A., Ellston R., Haworth C., Johnson T., et al. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. The Journal of Cell Biology 2003, 161:267-280.
35. Downes C.S., Clarke D.J., Mullinger A.M., Gimenez-Abian J.F., Creighton A.M., Johnson R.T. A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells. Nature 1994, 372:467-470.
36. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
37. Eliyahu D., Raz A., Gruss P., Givol D., Oren M. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature 1984, 312:646-649.
38. Falck J., Coates J., Jackson S.P. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 2005, 434:605-611.
39. Flatt P.M., Tang L.J., Scatena C.D., Szak S.T., Pietenpol J.A. p53 regulation of G(2) checkpoint is retinoblastoma protein dependent. Molecular and Cellular Biology 2000, 20:4210-4223.
40. Fontijn R.D., Goud B., Echard A., Jollivet F., van Marle J., Pannekoek H., et al. The human kinesin-like protein RB6K is under tight cell cycle control and is essential for cytokinesis. Molecular and Cellular Biology 2001, 21:2944-2955.
41. Fortune J.M., Osheroff N. Merbarone inhibits the catalytic activity of human topoisomerase IIalpha by blocking DNA cleavage. The Journal of Biological Chemistry 1998, 273:17643-17650.
42. Furnari B., Rhind N., Russell P. CDC25 mitotic inducer targeted by CHK1 DNA damage checkpoint kinase. Science 1997, 277:1495-1497.
43. Gadea B.B., Ruderman J.V. Aurora kinase inhibitor ZM447439 blocks chromosome-induced spindle assembly, the completion of chromosome condensation, and the establishment of the spindle integrity checkpoint in Xenopus egg extracts. Molecular Biology of the Cell 2005, 16:1305-1318.
44. Gassmann R., Carvalho A., Henzing A.J., Ruchaud S., Hudson D.F., Honda R., et al. Borealin: A novel chromosomal passenger required for stability of the bipolar mitotic spindle. The Journal of Cell Biology 2004, 166:179-191.
45. Girdler F., Gascoigne K.E., Eyers P.A., Hartmuth S., Crafter C., Foote K.M., et al. Validating Aurora B as an anti-cancer drug target. Journal of Cell Science 2006, 119:3664-3675.
46. Gizatullin F., Yao Y., Kung V., Harding M.W., Loda M., Shapiro G.I. The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. Cancer Research 2006, 66:7668-7677.
47. Goto H., Kiyono T., Tomono Y., Kawajiri A., Urano T., Furukawa K., et al. Complex formation of Plk1 and INCENP required for metaphase-anaphase transition. Nature Cell Biology 2006, 8:180-187.
48. Graeber T.G., Peterson J.F., Tsai M., Monica K., Fornace A.J., Giaccia A.J. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Molecular and Cellular Biology 1994, 14:6264-6277.
49. Green C.M., Erdjument-Bromage H., Tempst P., Lowndes N.F. A novel Rad24 checkpoint protein complex closely related to replication factor C. Current Biology: CB 2000, 10:39-42. [erratum appears in Curr Biol 2000 Feb 24;10(4):R171].
50. Griffiths D.J., Barbet N.C., McCready S., Lehmann A.R., Carr A.M. Fission yeast rad17: a homologue of budding yeast RAD24 that shares regions of sequence similarity with DNA polymerase accessory proteins. The EMBO Journal 1995, 14:5812-5823.
51. Gumireddy K., Reddy M.V., Cosenza S.C., Boominathan R., Baker S.J., Papathi N., et al. ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent. Cancer Cell 2005, 7:275-286.
52. Guse A., Mishima M., Glotzer M. Phosphorylation of ZEN-4/MKLP1 by aurora B regulates completion of cytokinesis. Current Biology: CB 2005, 15:778-786.
53. Harper J.W., Elledge S.J., Keyomarsi K., Dynlacht B., Tsai L.H., Zhang P., et al. Inhibition of cyclin-dependent kinases by p21. Molecular Biology of the Cell 1995, 6:387-400.
54. Harrington E.A., Bebbington D., Moore J., Rasmussen R.K., Ajose-Adeogun A.O., Nakayama T., et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nature Medicine 2004, 10:262-267.
55. Hauf S., Cole R.W., LaTerra S., Zimmer C., Schnapp G., Walter R., et al. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. The Journal of Cell Biology 2003, 161:281-294.
56. Hendzel M.J., Wei Y., Mancini M.A., Van Hooser A., Ranalli T., Brinkley B.R., et al. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 1997, 106:348-360.
57. Hirao A., Kong Y.Y., Matsuoka S., Wakeham A., Ruland J., Yoshida H., et al. DNA damage-induced activation of p53 by the checkpoint kinase CHK2. Science 2000, 287:1824-1827.
58. Hirota T., Lipp J.J., Toh B.H., Peters J.M. Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin. Nature 2005, 438:1176-1180.
59. Honda R., Korner R., Nigg E.A. Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. Molecular Biology of the Cell 2003, 14:3325-3341.
60. Hsu J.Y., Sun Z.W., Li X., Reuben M., Tatchell K., Bishop D.K., et al. Mitotic phosphorylation of histone H3 is governed by IPl1/aurora kinase and GLC7/PP1 phosphatase in budding yeast and nematodes. Cell 2000, 102:279-291.
61. Ishida S., Huang E., Zuzan H., Spang R., Leone G., West M., et al. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Molecular and Cellular Biology 2001, 21:4684-4699.
62. Jackson M.W., Agarwal M.K., Yang J., Bruss P., Uchiumi T., Agarwal M.L., et al. p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2. Journal of Cell Science 2005, 118:1821-1832.
63. Jazayeri A., Falck J., Lukas C., Bartek J., Smith G.C., Lukas J., et al. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nature Cell Biology 2006, 8:37-45.
64. Jeyaprakash A.A., Klein U.R., Lindner D., Ebert J., Nigg E.A., Conti E. Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together. Cell 2007, 131:271-285.
65. Jin P., Hardy S., Morgan D.O. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. The Journal of Cell Biology 1998, 141:875-885.
66. Kamijo K., Ohara N., Abe M., Uchimura T., Hosoya H., Lee J.S., et al. Dissecting the role of Rho-mediated signaling in contractile ring formation. Molecular Biology of the Cell 2006, 17:43-55.
67. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Research 1991, 51:6304-6311.
68. Katayama H., Sasai K., Kawai H., Yuan Z.M., Bondaruk J., Suzuki F., et al. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nature Genetics 2004, 36:55-62.
69. Khan S.H., Wahl G.M. p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest. Cancer Research 1998, 58:396-401.
70. Khanna K.K., Keating K.E., Kozlov S., Scott S., Gatei M., Hobson K., et al. ATM associates with and phosphorylates p53: Mapping the region of interaction. Nature Genetics 1998, 20:398-400.
71. Kharbanda S., Saleem A., Datta R., Yuan Z.M., Weichselbaum R., Kufe D. Ionizing radiation induces rapid tyrosine phosphorylation of p34cdc2. Cancer Research 1994, 54:1412-1414.
72. Klein U.R., Nigg E.A., Gruneberg U. Centromere targeting of the chromosomal passenger complex requires a ternary subcomplex of Borealin, Survivin, and the N-terminal domain of INCENP. Molecular Biology of the Cell 2006, 17:2547-2558.
73. Knowlton A.L., Lan W., Stukenberg P.T. Aurora B is enriched at merotelic attachment sites, where it regulates MCAK. Current Biology: CB 2006, 16:1705-1710.
74. Kops G.J., Foltz D.R., Cleveland D.W. Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:8699-8704.
75. Krystyniak A., Garcia-Echeverria C., Prigent C., Ferrari S. Inhibition of Aurora A in response to DNA damage. Oncogene 2006, 25:338-348.
76. Lane D. Cell immortalization and transformation by the p53 gene. Nature 1984, 312:596-597.
77. Lee E.A., Keutmann M.K., Dowling M.L., Harris E., Chan G., Kao G.D. Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells. Molecular Cancer Therapeutics 2004, 3:661-669.
78. Lee E.C., Frolov A., Li R., Ayala G., Greenberg N.M. Targeting Aurora kinases for the treatment of prostate cancer. Cancer Research 2006, 66:4996-5002.
79. Lindsey-Boltz L.A., Bermudez V.P., Hurwitz J., Sancar A. Purification and characterization of human DNA damage checkpoint Rad complexes. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:11236-11241.
80. Linke S.P., Clarkin K.C., Di Leonardo A., Tsou A., Wahl G.M. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes & Development 1996, 10:934-947.
81. Liu F., Stanton J.J., Wu Z., Piwnica-Worms H. The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex. Molecular and Cellular Biology 1997, 17:571-583.
82. Liu Q., Guntuku S., Cui X.S., Matsuoka S., Cortez D., Tamai K., et al. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes & Development 2000, 14:1448-1459.
83. Liu Q., Kaneko S., Yang L., Feldman R.I., Nicosia S.V., Chen J., et al. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215. The Journal of Biological Chemistry 2004, 279:52175-52182.
84. Livingstone L.R., White A., Sprouse J., Livanos E., Jacks T., Tlsty T.D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 1992, 70:923-935.
85. Lock R.B., Ross W.E. Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells. Cancer Research 1990, 50:3761-3766.
86. Lukas C., Melander F., Stucki M., Falck J., Bekker-Jensen S., Goldberg M., et al. MDC1 couples DNA double-strand break recognition by NBS1 with its H2AX-dependent chromatin retention. The EMBO Journal 2004, 23:2674-2683.
87. Mackay A.M., Eckley D.M., Chue C., Earnshaw W.C. Molecular analysis of the INCENPs (inner centromere proteins): separate domains are required for association with microtubules during interphase and with the central spindle during anaphase. The Journal of Cell Biology 1993, 123:373-385.
88. Mailand N., Diffley J.F. CDKs promote DNA replication origin licensing in human cells by protecting CDC6 from APC/C-dependent proteolysis. Cell 2005, 122:915-926.
89. Malkin D., Li F., Strong L., Fraumeni J., Nelson C., Kim D., et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990, 250:1233-1238.
90. Marumoto T., Hirota T., Morisaki T., Kunitoku N., Zhang D., Ichikawa Y., et al. Roles of aurora-A kinase in mitotic entry and G2 checkpoint in mammalian cells. Genes to Cells: Devoted to Molecular & Cellular Mechanisms 2002, 7:1173-1182.
91. Matsuoka S., Rotman G., Ogawa A., Shiloh Y., Tamai K., Elledge S.J. Ataxia telangiectasia-mutated phosphorylates chk2 in vivo and in vitro [in process citation]. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:10389-10394.
92. Mikhailov A., Shinohara M., Rieder C.L. Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway. The Journal of Cell Biology 2004, 166:517-526.
93. Minoshima Y., Kawashima T., Hirose K., Tonozuka Y., Kawajiri A., Bao Y.C., et al. Phosphorylation by aurora B converts MgcRacGAP to a RhoGAP during cytokinesis. Developmental Cell 2003, 4:549-560.
94. Mishima M., Kaitna S., Glotzer M. Central spindle assembly and cytokinesis require a kinesin-like protein/RhoGAP complex with microtubule bundling activity. Developmental Cell 2002, 2:41-54.
95. Monaco L., Kolthur-Seetharam U., Loury R., Murcia J.M., de Murcia G., Sassone-Corsi P. Inhibition of Aurora-B kinase activity by poly(ADP-ribosyl)ation in response to DNA damage. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:14244-14248.
96. Moore J.D., Yang J., Truant R., Kornbluth S. Nuclear import of CDK/cyclin complexes: identification of distinct mechanisms for import of CDK2/cyclin E and CDC2/cyclin B1. The Journal of Cell Biology 1999, 144:213-224.
97. Morrow C.J., Tighe A., Johnson V.L., Scott M.I., Ditchfield C., Taylor S.S. Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/Cdc20. Journal of Cell Science 2005, 118:3639-3652.
98. Murata-Hori M., Tatsuka M., Wang Y.L. Probing the dynamics and functions of aurora B kinase in living cells during mitosis and cytokinesis. Molecular Biology of the Cell 2002, 13:1099-1108.
99. Murata-Hori M., Wang Y.L. The kinase activity of aurora B is required for kinetochore-microtubule interactions during mitosis. Current Biology: CB 2002, 12:894-899.
100. Palframan W.J., Meehl J.B., Jaspersen S.L., Winey M., Murray A.W. Anaphase inactivation of the spindle checkpoint. Science 2006, 313:680-684.
101. Parker L.L., Piwnica-Worms H. Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science 1992, 257:1955-1957.
102. Passalaris T.M., Benanti J.A., Gewin L., Kiyono T., Galloway D.A. The G(2) checkpoint is maintained by redundant pathways. Molecular and Cellular Biology 1999, 19:5872-5881.
103. Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M., Bonner W.M. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Current Biology: CB 2000, 10:886-895.
104. Peng C.Y., Graves P.R., Thoma R.S., Wu Z., Shaw A.S., Piwnica-Worms H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of CDC25C on serine-216. Science 1997, 277:1501-1505.
105. Pines J., Hunter T. Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. The Journal of Cell Biology 1991, 115:1-17.
106. Polager S., Kalma Y., Berkovich E., Ginsberg D. E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis. Oncogene 2002, 21:437-446.
107. Ren B., Cam H., Takahashi Y., Volkert T., Terragni J., Young R.A., et al. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes & Development 2002, 16:245-256.
108. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. The Journal of Biological Chemistry 1998, 273:5858-5868.
109. Rossi R., Lidonnici M.R., Soza S., Biamonti G., Montecucco A. The dispersal of replication proteins after Etoposide treatment requires the cooperation of NBS1 with the ataxia telangiectasia Rad3-related/CHK1 pathway. Cancer Research 2006, 66:1675-1683.
110. Rudolph N.S., Latt S.A. Flow cytometric analysis of X-ray sensitivity in ataxia telangiectasia. Mutation Research 1989, 211:31-41.
111. Sanchez Y., Wong C., Thoma R.S., Richman R., Wu Z., Piwnica-Worms H., et al. Conservation of the CHK1 checkpoint pathway in mammals: linkage of DNA damage to CDK regulation through CDC25. Science 1997, 277:1497-1501.
112. Sasai K., Katayama H., Stenoien D.L., Fujii S., Honda R., Kimura M., et al. Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells. Cell Motility and the Cytoskeleton 2004, 59:249-263.
113. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995, 268:1749-1753.
114. Schwartz G.K., Ilson D., Saltz L., O'Reilly E., Tong W., Maslak P., et al. Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2001, 19:1985-1992.
115. Sen S., Zhou H., White R.A. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 1997, 14:2195-2200.
116. Sen S., Zhou H., Zhang R.D., Yoon D.S., Vakar-Lopez F., Ito S., et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. Journal of the National Cancer Institute 2002, 94:1320-1329.
117. Shieh S.Y., Ikeda M., Taya Y., Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997, 91:325-334.
118. Siliciano J.D., Canman C.E., Taya Y., Sakaguchi K., Appella E., Kastan M.B. DNA damage induces phosphorylation of the amino terminus of p53. Genes & Development 1997, 11:3471-3481.
119. Smith K.A., Gorman P.A., Stark M.B., Groves R.P., Stark G.R. Distinctive chromosomal structures are formed very early in the amplification of CAD genes in Syrian hamster cells. Cell 1990, 63:1219-1227.
120. Smith K.A., Stark M.B., Gorman P.A., Stark G.R. Fusions near telomeres occur very early in the amplification of CAD genes in Syrian hamster cells. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:5427-5431.
121. Sogo J.M., Lopes M., Foiani M. Fork reversal and ssDNA accumulation at stalled replication forks owing to checkpoint defects. Science 2002, 297:599-602.
122. Sorrentino R., Libertini S., Pallante P.L., Troncone G., Palombini L., Bavetsias V., et al. Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation. The Journal of Clinical Endocrinology and Metabolism 2005, 90:928-935.
123. Srivastava S., Zou Z., Pirollo K., Blattner W., Chang E. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990, 348:747-749.
124. Stewart N., Hicks G.G., Paraskevas F., Mowat M. Evidence for a second cell cycle block at G2/M by p53. Oncogene 1995, 10:109-115.
125. Sudo T., Nitta M., Saya H., Ueno N.T. Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint. Cancer Research 2004, 64:2502-2508.
126. Takizawa C.G., Weis K., Morgan D.O. Ran-independent nuclear import of cyclin B1-Cdc2 by importin beta. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:7938-7943.
127. Tao W., South V.J., Zhang Y., Davide J.P., Farrell L., Kohl N.E., et al. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Cancer Cell 2005, 8:49-59.
128. Tarnawski A., Pai R., Chiou S.K., Chai J., Chu E.C. Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B. Biochemical and Biophysical Research Communications 2005, 334:207-212.
129. Taylor W.R., DePrimo S.E., Agarwal A., Agarwal M.L., Schonthal A.H., Katula K.S., et al. Mechanisms of G2 arrest in response to overexpression of p53. Molecular Biology of the Cell 1999, 10:3607-3622.
130. Taylor W.R., Schonthal A.H., Galante J., Stark G.R. p130/E2F4 binds to and represses the CDC2 promoter in response to p53. The Journal of Biological Chemistry 2001, 276:1998-2006.
131. Thullberg M., Bartkova J., Khan S., Hansen K., Ronnstrand L., Lukas J., et al. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors. FEBS Letters 2000, 470:161-166.
132. Tibbetts R.S., Brumbaugh K.M., Williams J.M., Sarkaria J.N., Cliby W.A., Shieh S.Y., et al. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes & Development 1999, 13:152-157.
133. Tlsty T.D. Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:3132-3136.
134. Toczyski D.P., Galgoczy D.J., Hartwell L.H. CDC5 and CKII control adaptation to the yeast DNA damage checkpoint. Cell 1997, 90:1097-1106.
135. Toyoshima-Morimoto F., Taniguchi E., Shinya N., Iwamatsu A., Nishida E. Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase. Nature 2001, 410:215-220.
136. Uetake Y., Sluder G. Cell cycle progression after cleavage failure: mammalian somatic cells do not possess a "tetraploidy checkpoint. The Journal of Cell Biology 2004, 165:609-615.
137. Vader G., Kauw J.J., Medema R.H., Lens S.M. Survivin mediates targeting of the chromosomal passenger complex to the centromere and midbody. EMBO Reports 2006, 7:85-92.
138. Venclovas C., Thelen M.P. Structure-based predictions of RAD1, RAD9, HUS1 and RAD17 participation in sliding clamp and clamp-loading complexes. Nucleic Acids Research 2000, 28:2481-2493.
139. Ward I.M., Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. The Journal of Biological Chemistry 2001, 276:47759-47762.
140. Wheatley S.P., Henzing A.J., Dodson H., Khaled W., Earnshaw W.C. Aurora-B phosphorylation in vitro identifies a residue of survivin that is essential for its localization and binding to inner centromere protein (INCENP) in vivo. The Journal of Biological Chemistry 2004, 279:5655-5660.
141. Wheatley S.P., Kandels-Lewis S.E., Adams R.R., Ainsztein A.M., Earnshaw W.C. INCENP binds directly to tubulin and requires dynamic microtubules to target to the cleavage furrow. Experimental Cell Research 2001, 262:122-127.
142. Williams B.C., Li Z., Liu S., Williams E.V., Leung G., Yen T.J., et al. Zwilch, a new component of the ZW10/ROD complex required for kinetochore functions. Molecular Biology of the Cell 2003, 14:1379-1391.
143. Wolf G., Hildenbrand R., Schwar C., Grobholz R., Kaufmann M., Stutte H.J., et al. Polo-like kinase: a novel marker of proliferation: Correlation with estrogen-receptor expression in human breast cancer. Pathology, Research and Practice 2000, 196:753-759.
144. Wong C., Stearns T. Mammalian cells lack checkpoints for tetraploidy, aberrant centrosome number, and cytokinesis failure. BMC Cell Biology 2005, 6:6.
145. Wright J.A., Smith H.S., Watt F.M., Hancock M.C., Hudson D.L., Stark G.R. DNA amplification is rare in normal human cells. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:1791-1795.
146. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993, 366:701-704.
147. Yan X., Cao L., Li Q., Wu Y., Zhang H., Saiyin H., et al. Aurora C is directly associated with survivin and required for cytokinesis. Genes to Cells: Devoted to Molecular & Cellular Mechanisms 2005, 10:617-626.
148. Yan X., Wu Y., Li Q., Cao L., Liu X., Saiyin H., Yu L. Cloning and characterization of a novel human Aurora C splicing variant. Biochemical and Biophysical Research Communications 2005, 328:353-361.
149. Yang D., Welm A., Bishop J.M. Cell division and cell survival in the absence of survivin. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:15100-15105.
150. Yang J., Bardes E.S., Moore J.D., Brennan J., Powers M.A., Kornbluth S. Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1. Genes & Development 1998, 12:2131-2143.
151. Yin Y., Tainsky M.A., Bischoff F.Z., Strong L.C., Wahl G.M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 1992, 70:937-948.
152. Young M.A., Shah N.P., Chao L.H., Seeliger M., Milanov Z.V., Biggs W.H., et al. Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the Aurora kinase inhibitor VX-680. Cancer Research 2006, 66:1007-1014.
153. Yuce O., Piekny A., Glotzer M. An ECT2-centralspindlin complex regulates the localization and function of RhoA. The Journal of Cell Biology 2005, 170:571-582.
154. Zeitlin S.G., Shelby R.D., Sullivan K.F. CENP-A is phosphorylated by Aurora B kinase and plays an unexpected role in completion of cytokinesis. The Journal of Cell Biology 2001, 155:1147-1157.
155. Zhou H., Kuang J., Zhong L., Kuo W.L., Gray J.W., Sahin A., et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nature Genetics 1998, 20:189-193.
156. Abraham R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes & Development 2001, 15:2177-2196.
157. Altieri D.C. Validating survivin as a cancer therapeutic target. Nature Reviews. Cancer 2003, 3:46-54.
158. Appella E., Anderson C.W. Post-translational modifications and activation of p53 by genotoxic stresses. European Journal of Biochemistry / FEBS 2001, 268:2764-2772.
159. Barbacid M., Ortega S., Sotillo R., Odajima J., Martin A., Santamaria D., et al. Cell cycle and cancer: genetic analysis of the role of cyclin-dependent kinases. Cold Spring Harbor Symposia on Quantitative
160. Bartek J., Lukas J., Bartkova J. Perspective: Defects in cell cycle control and cancer. The Journal of Pathology 1999, 187:95-99.
161. Bernhard E.J., Maity A., Muschel R.J., McKenna W.G. Effects of ionizing radiation on cell cycle progression. A review. Radiation & Environmental Biophysics 1995, 34:79-83.
162. Bernhard E.J., McKenna W.G., Muschel R.J. Radiosensitivity and the cell cycle. Cancer Journal from Scientific American 1999, 5:194-204.
163. Bolanos-Garcia V.M. Aurora kinases. The International Journal of Biochemistry & Cell Biology 2005, 37:1572-1577.
164. Boulaire J., Fotedar A., Fotedar R. The functions of the CDK-cyclin kinase inhibitor p21WAF1. Pathologie-biologie 2000, 48:190-202.
165. Brinkley B.R., Goepfert T.M. Supernumerary centrosomes and cancer: Boveri's hypothesis resurrected. Cell Motility and the Cytoskeleton 1998, 41:281-288.
166. Brittle A.L., Ohkura H. Centrosome maturation: Aurora lights the way to the poles. Current Biology: CB 2005, 15:R880-R882.
167. Brown J.R., Koretke K.K., Birkeland M.L., Sanseau P., Patrick D.R. Evolutionary relationships of Aurora kinases: Implications for model organism studies and the development of anti-cancer drugs. BMC Evolutionary Biology 2004, 4:39.
168. Cam H., Dynlacht B.D. Emerging roles for E2F: Beyond the G1/S transition and DNA replication. Cancer Cell 2003, 3:311-316.
169. Chan G.K., Liu S.T., Yen T.J. Kinetochore structure and function. Trends in Cell Biology 2005, 15:589-598.
170. Cortez D. Unwind and slow down: Checkpoint activation by helicase and polymerase uncoupling. Genes & Development 2005, 19:1007-1012.
171. D'Amours D., Jackson S. The MRE11 complex: at the crossroads of DNA repair and checkpoint signaling. Nature Reviews. Molecular Cell Biology 2002, 3:317-327.
172. Doggrell S.A. Dawn of Aurora kinase inhibitors as anticancer drugs. Expert Opinion on Investigational Drugs 2004, 13:1199-1201.
173. Dong Z., Bode A.M. The role of histone H3 phosphorylation (Ser10 and Ser28) in cell growth and cell transformation. Molecular Carcinogenesis 2006, 45:416-421.
174. Draetta G., Eckstein J. CDC25 protein phosphatases in cell proliferation. Biochimica et Biophysica Acta 1997, 1332:M53-63.
175. Ducat D., Zheng Y. Aurora kinases in spindle assembly and chromosome segregation. Experimental Cell Research 2004, 301:60-67.
176. Elledge S.J. Cell cycle checkpoints: Preventing an identity crisis. Science 1996, 274:1664-1672.
177. Froelich-Ammon S.J., Osheroff N. Topoisomerase poisons: Harnessing the dark side of enzyme mechanism. The Journal of Biological Chemistry 1995, 270:21429-21432.
178. Gautschi O., Mack P.C., Davies A.M., Lara P.N., Gandara D.R. Aurora kinase inhibitors: A new class of targeted drugs in cancer. Clinical Lung Cancer 2006, 8:93-98.
179. Giet R., Petretti C., Prigent C. Aurora kinases, aneuploidy and cancer, a coincidence or a real link?. Trends in Cell Biology 2005, 15:241-250.
180. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Research 1994, 54:4855-4878.
181. Hagan R.S., Sorger P.K. Cell biology: The more MAD, the merrier. Nature 2005, 434:575-577.
182. Harbour J.W., Dean D.C. Rb function in cell-cycle regulation and apoptosis. Nature Cell Biology 2000, 2:E65-E67.
183. Hirano T. Chromosome cohesion, condensation, and separation. Annual Review of Biochemistry 2000, 69:115-144.
184. Kadura S., Sazer S. SAC-ing mitotic errors: How the spindle assembly checkpoint (SAC) plays defense against chromosome mis-segregation. Cell Motility and the Cytoskeleton 2005, 61:145-160.
185. Kastan M.B., Bartek J. Cell-cycle checkpoints and cancer. Nature 2004, 432:316-323.
186. Katayama H., Brinkley W.R., Sen S. The Aurora kinases: Role in cell transformation and tumorigenesis. Cancer Metastasis Reviews 2003, 22:451-464.
187. Keen N., Taylor S. Aurora-kinase inhibitors as anticancer agents. Nature Reviews. Cancer 2004, 4:927-936.
188. Lee J.J., Swain S.M. Peripheral neuropathy induced by microtubule-stabilizing agents. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2006, 24:1633-1642.
189. Lowndes N.F., Murguia J.R. Sensing and responding to DNA damage. Current Opinion in Genetics & Development 2000, 10:17-25.
190. Maity A., McKenna W.G., Muschel R.J. The molecular basis for cell cycle delays following ionizing radiation: A review. Radiotherapy & Oncology 1994, 31:1-13.
191. McGowan C.H. Checking in on CDS1 (CHK2): A checkpoint kinase and tumor suppressor. BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology 2002, 24:502-511.
192. Mistry S.J., Atweh G.F. Role of stathmin in the regulation of the mitotic spindle: Potential applications in cancer therapy. The Mount Sinai Journal of Medicine, New York 2002, 69:299-304.
193. Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Proliferation 2000, 33:261-274.
194. Momand J., Wu H.H., Dasgupta G. MDM2-Master regulator of the p53 tumor suppressor protein. Gene 2000, 242:15-29.
195. Nurse P. Universal control mechanism regulating onset of M-phase. Nature 1990, 344:503-508.
196. O'Connell M.J., Walworth N.C., Carr A.M. The G2-phase DNA-damage checkpoint. Trends in Cell Biology 2000, 10:296-303.
197. Pines J. Cyclins and cyclin-dependent kinases: a biochemical view. The Biochemical Journal 1995, 308:697-711.
198. Pinsky B.A., Biggins S. The spindle checkpoint: Tension versus attachment. Trends in Cell Biology 2005, 15:486-493.
199. Prigent C., Dimitrov S. Phosphorylation of serine 10 in histone H3, what for?. Journal of Cell Science 2003, 116:3677-3685.
200. Reichard P. Ribonucleotide reductases: The evolution of allosteric regulation. Archives of Biochemistry and Biophysics 2002, 397:149-155.
201. Smits V.A., Medema R.H. Checking out the G(2)/M transition. Biochimica et Biophysica Acta 2001, 1519:1-12.
202. Stark G.R., Taylor W.R. Control of the G2/M transition. Molecular Biotechnology 2006, 32:227-248.
203. Trimarchi J.M., Lees J.A. Sibling rivalry in the E2F family. Nature Reviews. Molecular Cell Biology 2002, 3:11-20.
204. Vader G., Medema R.H., Lens S.M. The chromosomal passenger complex: Guiding Aurora-B through mitosis. The Journal of Cell Biology 2006, 173:833-837.
205. Vagnarelli P., Earnshaw W.C. Chromosomal passengers: The four-dimensional regulation of mitotic events. Chromosoma 2004, 113:211-222.
206. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
207. Weaver B.A., Cleveland D.W. Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death. Cancer Cell 2005, 8:7-12.
208. Dash B.C., El-Deiry W.S. Cell cycle checkpoint control mechanisms that can be disrupted in cancer. Methods in Molecular Biology (Clifton, N. J.) 2004, 280:99-161.
209. Nojima H. G1 and S-phase checkpoints, chromosome instability, and cancer. Methods in Molecular Biology (Clifton) 2004, 280:3-49.